These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28708873)

  • 21. Early induction of leukemia inhibitor factor (LIF) in acute HIV-1 infection.
    Tjernlund A; Barqasho B; Nowak P; Kinloch S; Thorborn D; Perrin L; Sönnerborg A; Walther-Jallow L; Andersson J
    AIDS; 2006 Jan; 20(1):11-9. PubMed ID: 16327314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy.
    Craigo JK; Patterson BK; Paranjpe S; Kulka K; Ding M; Mellors J; Montelaro RC; Gupta P
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1196-209. PubMed ID: 15588342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV dynamics in seminal plasma during primary HIV infection.
    Stekler J; Sycks BJ; Holte S; Maenza J; Stevens CE; Dragavon J; Collier AC; Coombs RW
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1269-74. PubMed ID: 18844461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
    Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
    Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    Palich R; Ghosn J; Chaillon A; Boilet V; Nere ML; Chaix ML; Delobel P; Molina JM; Lucht F; Bouchaud O; Rieux V; Thiebaut R; Levy Y; Delaugerre C; Lelievre JD;
    AIDS; 2019 Feb; 33(2):279-284. PubMed ID: 30325777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
    PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma.
    Winter AJ; Taylor S; Workman J; White D; Ross JD; Swan AV; Pillay D
    Sex Transm Infect; 1999 Aug; 75(4):261-3. PubMed ID: 10615314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection.
    Trémeaux P; Lenfant T; Boufassa F; Essat A; Mélard A; Gousset M; Delelis O; Viard JP; Bary M; Goujard C; Rouzioux C; Meyer L; Avettand-Fenoel V;
    EBioMedicine; 2019 Mar; 41():455-464. PubMed ID: 30803934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
    Osborne BJ; Sheth PM; Yi TJ; Kovacs C; Benko E; Porte Cl; Huibner S; Le AQ; Danroth R; Baraki B; Mazzulli T; Brumme ZL; Kaul R
    J Infect Dis; 2013 Apr; 207(8):1226-34. PubMed ID: 23329849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
    Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
    J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
    Péré H; Rascanu A; LeGoff J; Matta M; Bois F; Lortholary O; Leroy V; Launay O; Bélec L;
    Int J STD AIDS; 2016 Mar; 27(3):178-85. PubMed ID: 25769886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.
    Gianella S; Chaillon A; Chun TW; Sneller MC; Ignacio C; Vargas-Meneses MV; Caballero G; Ellis RJ; Kovacs C; Benko E; Huibner S; Kaul R
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes.
    Bujan L; Daudin M; Matsuda T; Righi L; Thauvin L; Berges L; Izopet J; Berrebi A; Massip P; Pasquier C
    AIDS; 2004 Mar; 18(5):757-66. PubMed ID: 15075510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of HIV-1 from semen and blood from clade C-infected subjects from India and effect of therapy in these body compartments.
    Shen C; Ding M; Craigo JK; Tarwater P; Chatterjee R; Roy P; Guha SK; Saha B; Modak D; Neogi D; Chen Y; Gupta P
    Virology; 2010 Jun; 401(2):190-6. PubMed ID: 20231027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection.
    Mariaggi AA; Bauer R; Charre C; Gardiennet E; Meiffredy V; Ajana F; Lacombe K; Pialoux G; Cua E; Rouzioux C; Meyer L; Cheret A; Avettand-Fenoel V
    J Antimicrob Chemother; 2022 Feb; 77(3):735-739. PubMed ID: 35195692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV RNA and proviral HIV DNA can be detected in semen after 6 months of antiretroviral therapy although HIV RNA is undetectable in blood.
    Du P; Liu A; Jiao Y; Liu C; Jiang T; Zhu W; Zhu Y; Wu H; Sun L
    Microbiol Immunol; 2016 Mar; 60(3):187-95. PubMed ID: 26833915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
    de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
    Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission.
    Tachet A; Dulioust E; Salmon D; De Almeida M; Rivalland S; Finkielsztejn L; Heard I; Jouannet P; Sicard D; Rouzioux C
    AIDS; 1999 May; 13(7):823-31. PubMed ID: 10357382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial.
    Gutierrez-Valencia A; Benmarzouk-Hidalgo OJ; Rivas-Jeremías I; Espinosa N; Trujillo-Rodríguez M; Fernandez-Magdaleno T; Viciana P; López-Cortés LF
    Clin Infect Dis; 2017 Aug; 65(4):551-556. PubMed ID: 28449051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.